
Canada Follow The US And Recalls Several Diabetes Medications Over Cancer Risk
Canada has followed the lead of the United States and is pulling medicines thought to become carcinogenic from store shelves
Monday, June 15, 2020 - The US Food and Drug Administration has created a frenzy of regulatory activity about the safety of the world's leading heartburn medicine Zantac. Investigations are proceeding at full speed to determine what levels N-nitrosodimethylamine (NDMA) increases when exposed to high temperatures and also the carcinogen's interactions with nitrates within the stomach. Hundreds of individuals with stomach, bladder, prostate, and many other types of cancer have consulted Zantac Cancer Lawyers and have filed lawsuits seeking damages for their physical, emotional, and financial suffering. Both Sanofi, the maker of Zantac, and the FDA have advised recalling Zantac and other heartburn and acid reflux medicines from store shelves in the US and Canada pending the investigations. Canada is as concerned as the US and has taken steps to recall type 2 diabetes drugs that may be harming consumers. Type 2 diabetes drugs work to redirect sugar out of the body through the urine for diabetic patients that do not want to inject themselves with insulin daily.
Health Canada announced the other day that Apotex Inc, Canada's leading diabetic drug manufacturer, would comply with the government's advisory and voluntarily withdraw prescription the diabetes drug metformin Apo-Metformin ER (extended-release) 500-milligram tablets from the market immediately. In line with other drugs such as blood pressure and heartburn, diabetic drugs have been found to have elevated levels of NDMA that may be considered carcinogenic (cancer-causing). It is feared that storing the drug at high temperatures may cause the NDMA to increase. The agency's NDMA public health concerns were stoked by the repetitive nature of taking daily type 2 diabetes pills even though NDMA ingested only occasionally and in microscopically low dosed was considered safe. The FDA's acceptable limit for NDMA is 96 ng (nanograms) per unit and online testing pharmacy Valisure discovered levels many thousands of times above that causing concern and prompting the company to file a citizen petition to call the research to the US FDA's attention.
Health Canada has continued to err on the side of caution and the Apotex recall follows in line with others. According to CTV News Canada, |"In March, JAMP Pharma Corporation voluntarily recalled 26 lots of its metformin drug due to the potential presence of nitrosamine impurities in the finished product. And Ranbaxy Pharmaceuticals Canada Inc. recalled six lots of its prescription RAN-Metformin drug over NDMA levels in February. Also in February, Health Canada issued a similar recall for eight lots of Apotex's APO-Metformin ER tablets sold in 500-milligram tablets."
The news of unpredictability in the safety of Canada's diabetic drugs is particularly concerning to Canadians as research indicates approximately one in every three Canadians suffers from diabetes or prediabetes. Government health authorities in the US and Canada warn diabetic patients to continue taking their medication as prescribed and if concerned to contact their physician for guidance. Discontinuing diabetic medication can have serious, life-threatening consequences. Those with diabetes live with the daily risk of developing a stroke, heart attack, acute kidney failure, and limb amputation.
More Recent Heartburn MedicineLawsuit News:
- The Department of Justice Points To a 1983 Study That Found Accelerated Levels of NDMA in ranitidine | 3/3/2021
- Zantac Remains Off Of Store Shelves More Than A Year After NDMA Contamination Was Discovered | 3/2/2021
- Vitamins Can Help Regulate Stomach Acid | 2/27/2021
- Online Pharmacy Can Fill Prescriptions After Testing Your Drugs For Purity and Safety | 2/22/2021
- Walmart And CVS Are Co-Defendants in Ranitidine (Zantac) Cancer Lawsuits | 2/17/2021
- More Ways To Alleviate Heartburn Pain With Zantac No Longer Available | 2/16/2021
- Gradual Lifestyle Changes Can Cure Heartburn And Acid Reflux Disease | 2/15/2021
- Purity Certification May Have To Be Met If Zantac Could Ever Be Sold Again | 2/10/2021
- Zantac Alternatives May Cause Serious Diseases | 2/9/2021
- Constant Use of Heartburn and Acid Reflux Drugs Like Zantac Could Double Cancer Risks | 2/5/2021
- Ranitidine Is Unstable According to Valisure | 2/2/2021
- Heartburn Sufferers Look To PPI Drugs To Control Acid Reflux Disease and GERD | 2/1/2021
- California Zantac Plaintiffs Want State Court To Hear Their Cases | 1/29/2021
- Zantac Cancer Issues Are Affecting People In Europe, Canada, and The United States | 1/28/2021
- Former Zantac Users Need To Exercise a Little Common Sense | 1/27/2021
- The FDA Did Not Follow-Up Test Zantac Until Too Late | 1/25/2021
- Estates of the Desceased Can File a Zantac Cancer Lawsuit | 1/21/2021
- Zantac Cancer Prompts FDA To Seek Answers | 1/20/2021
- People May Be Exposed To NDMA From Many Sources | 1/19/2021
- Valisure CEO Infers Ranitidine (Zantac) May Be Unstable And Degrade On Its Own | 1/18/2021
- The Types of Zantac Cancer Identified In Multidistrict Litigation | 1/13/2021
- Zantac Cancer Trials Consolidated In Federal Court | 1/10/2021
- Facts About Filing A Zantac Cancer Lawsuit | 1/8/2021
- Zantac Cancer Claims Organized In Florida Multi-District Litigation | 1/6/2021
- Sanofi Could Be Guilty Of Failing To Disclose the potential presence of N-Nitrosodimethylamine (NDMA) in Zantac | 1/5/2021
- Ranitidine Zantac Cancer Will Make Headlines in 2021 | 1/4/2021
- FDA Recall of Zantac Ranks As One Of The Most Important Human Health Developments of 2020 | 12/28/2020
- Zantac Users May Require Surgery To Repair A Valve In Their Esophagus | 12/23/2020
- Study Finds Ranitidine (Zantac) May Be Inherently Unstable | 12/21/2020
- CEO Testimony May Implicate China As The Source Of Zantac NDMA Contamination | 12/16/2020
- Lockdowns Are Causing Obesity Heartburn Medicines Are In Short Supply | 12/14/2020
- Zantac And Ranitidine Are Recalled And The Alternatives Are In Short Supply | 12/11/2020
- Potential Zantac Cancer Plaintiffs Should Organize Their Documents | 12/9/2020
- Zantac Lawsuits Point To An Array of Negligence By Sanofi | 12/7/2020
- Ranitidine Could Be Back On The Market In Canada If The Manufacturer Meets Certain Conditions | 12/4/2020
- Scientific Experts Hired By Plaintiffs May Uncover The Reason Zantac Allegedly Causes Cancer | 12/1/2020
- November Review of Important Zantac Cancer Developments | 11/25/2020
- Advice For Former Zantac Patients Now That The Heartburn Drug Is No Longer Available | 11/23/2020
- Potential Zantac Plaintiffs Must Provide A Record Of Using The Medine | 11/19/2020
- Nitrates Suspected To Have Caused Zantac Contamination | 11/18/2020
- Military Veterans May Be Developing More Zantac Cancer Than The General Population | 11/17/2020
- The Failure To Oversee Chinese Drug Manufacturing May Have Led To Zantac Cancer Contamination | 11/16/2020
- Surviving Spouses And The Children of Those Who Have Died From Cancer Are Filing Zantac Cancer Lawsuits | 11/10/2020
- Heartburn Management Centers Seek To Capitalize on Zantac Ban | 11/7/2020
- Recalls Accelerating For Heartburn, Blood Pressure, and Type 2 Diabetes Drugs Over Cancer Fears | 11/4/2020
- China And India Could Be The Source of Zantac Contamination | 11/2/2020
- Sanofi Under Criminal Investigation By The US Department of Justice For False Claims Act Violations | 10/29/2020
- Zantac Alternative Drugs Recommended By The FDA May Cause Memory Loss | 10/27/2020
- Scientists Focus On India And China As Source of Zantac Contamination | 10/26/2020
- Zantac May Cause Type-2 Diabetes As Well As Many Types of Cancer | 10/21/2020
- Discovery Proceeding in Zantac Cancer Litigation | 10/20/2020
- Heartburn Drug Manufacturer Sanofi Could Be Forced To Regularly Test Zantac For Carcinogens | 10/16/2020
- Researchers Continue to Struggle To Determine Why Zantac Could Cause Cancer | 10/12/2020
- Popular Zantac Alternative Drugs May Cause Type-2 Diabetes | 10/10/2020
- Tens Of Millions of Zantac Users May Develop Cancer | 10/7/2020
- Online Medical Experts Offer Advice On Dealing With Zantac Recall | 10/6/2020
- Sanofi May Have Known For Years That Zantac Could Cause Cancer | 10/5/2020
- Thousands of Former Zantac User Fear Cancer Diagnosis in Their Future | 10/1/2020
- Stomach Cancer Could Have Been Easily Treatable If Sanofi Warned of Zantac Cancer Sooner | 9/30/2020
- Administrative Procedures Organized in Lawsuits That Claim Zantac Caused Cancer | 9/28/2020
- Sanofi May Have Had An Obligation To Know That Zantac Could Cause Cancer | 9/24/2020
- Taking Zantac Was An Elective Decision Not A Medical Necessity | 9/23/2020
- Many Zantac Users Fear Stomach Cancer From Taking The Drug | 9/22/2020
- Many Zantac Users Fear Stomach Cancer From Taking The Drug | 9/21/2020
- Millions Were Left With Heartburn and Acid-Reflux Pain When Ranitidine (Zantac) Was Recalled | 9/17/2020
- Zantac Patients Are Advised Not To Abuse Their New PPI Drugs | 9/15/2020
- Plaintiffs Blame Zantac For Causing Colon Cancer | 9/14/2020
- Government Health Officials in The US and Canada Worry Zantac Cancer Could Affect Millions | 9/9/2020
- Zantac Prostate Cancer Has Men That Used Zantac Worried | 9/7/2020
- Zantac Cancer Contamination Could Occur In the Body | 8/31/2020
- Zantac Users Have Alternative Treatments That Diabetics and Others May Not | 8/29/2020
- Zantac Users Patiently Await Answers About Zantac Cancer | 8/26/2020
- Studies Find NDMA Increases For More Reasons Than High Temperatures Alone | 8/24/2020
- Understanding The Science of Zantac Breast Cancer | 8/15/2020
- Previous Zantac Users Should Make Lifestyle Changes | 8/12/2020
- Women Are Alarmed That Zantac May Cause Breast Cancer | 8/11/2020
- Removing Zantac From The Market Could Lead To People Developing Esophageal Cancer | 8/10/2020
- Alternative FDA Testing Methods Did Not Find Zantac To Be Dangerous | 8/6/2020
- An Online Testing Pharmacy May Have Jumped The Gun When Reporting Dangerous NDMA Levels | 8/5/2020
- Valisure's Testing Methods May Be Flawed And The Cause Of The Spike in NDMA | 8/3/2020
- Experts Are Trying To Understand NDMA | 7/31/2020
- Online Testing Pharmacy May Have Saved Millions From Zantac Cancer | 7/30/2020
- The FDA Falls Short in Zantac Cancer Testing | 7/28/2020
- Zantac Cancer May Be America's Next Public Health Crisis | 7/22/2020
- Cancer's Latency Could Drive Zantac Cancer Claims For Years | 7/20/2020
- Online Experts Warn Of The Dangers of Developing Zantac Cancer | 7/14/2020
- Zantac and Generic Ranitidine Heartburn Medicine Recalled Because of Cancer Link | 7/13/2020
- Former Zantac Users Have Few Options Left Other Than Adopting a Healthy Lifestyle | 7/10/2020
- Zantac Alternative Medicines May Increase The Risk of Contracting The Coronavirus | 7/8/2020
- Cases Are Being Consolidated Against Sanofi By Alleged Zantac Cancer Sufferers | 7/7/2020
- Zantac Users Should Consider Safer Alternative Drugs | 7/1/2020
- Nitrosamines NDMA Levels in Zantac Found To Be Thousands of Time Higher Than Acceptable | 6/30/2020
- The Zantac Cancer Scare Is Leading To Other Drug Recalls Throughout North America | 6/29/2020
- The Legal Process Has Started To Grind Against Heartburn Drug Manufacturers and Others | 6/24/2020
- Zantac Users Left Without Heartburn Medication By The Drugs Recalls | 6/22/2020
- Updated Guidance From The FDA Regarding Ranitidine, Zantac | 6/18/2020
- Diabetic Patients That Stop Taking Metformin Could Face Serious Health Complications | 6/16/2020
- It Has Been One Year Since Researchers Found a Carcinogen In Blood Pressure Medicine | 6/11/2020
- Finding Cancer Causing Chemicals in Heartburn Drugs Like Zantac May Be Only The Beginning | 6/10/2020
- Every Day Another Company Recalls Their Blood Pressure, Heartburn, or Diabetes Drug Due to Cancer Concerns | 6/8/2020
- Zantac Cancer May Be The Impetus Needed To Bring The US Drug Manufacturing Supply Chain Home | 6/5/2020
- Heartburn, Diabetes, and Blood Pressure Drugs May Contain Dangerously High Levels of a Carcinogen Called NDMA | 6/4/2020
- The FDA Is Forcing Some Diabetic Drug Manufacturers to Pull Their Type 2 Products From Store Shelves | 6/1/2020
- The FDA May Require Stricter Regulation of Foreign Drug Manufacturers | 5/29/2020
- Former Zantac Users Should Watch For Gastro-Intestinal Cancer Symptoms | 5/28/2020
- Lawsuits Continue To Be Filed Claiming Zantac Causes Cancer | 5/26/2020
- Global Concerns Over Zantac Cancer | 5/19/2020
- Breast Cancer Is The Latest Disease Allegedly Caused By Zantac | 5/18/2020
- Medical Expert Opinions Are Mixed About Zantac Being Carcinogenic | 5/12/2020
- Pepcid Anti-Heartburn Drug Sought To Treat Covid19 | 5/8/2020
- Heartburn Drugs May Be In Short Supply At Local Pharmacy | 5/6/2020
- FDA Recommended Heartburn Drugs May Cause Kidney Failure and Osteoperosis | 5/5/2020
- Zantac Users May Want to be Checked For Gastro-Intestinal Cancers | 5/1/2020
- Despite Zantac's Recall Other Antacid Medication Offer Promise To Help Alleviate COVID19 | 4/28/2020
- Zantac is Blamed For Causing Gastric Cancer | 4/23/2020
- Zantac Users Should Hold On To or Mail Back Unused Portions Instead Of Physically Returning The Drug | 4/20/2020
- Expert Advice For Previously Heavy Zantac Users | 4/16/2020
- Making Simple Dietary Changes Can Replace The Need For Antacids | 4/15/2020
- Lawsuit Alleges Zantac Caused Plaintiff's Colon Cancer | 4/13/2020
- Cancer-Causing Compound Leads to Diabetes Drug Recalls | 4/10/2020
- Lawsuits Are Being Considered By Heartburn Drug Cancer Victims | 4/9/2020
- Lawsuits Have Been Filed After Tests Show Triple the Allowable Levels of NDMA in Antacid drugs | 4/8/2020
- Popular Over-The-Counter Heartburn Pills May Cause Stomach Cancer | 4/7/2020
- Popular Anti-acid Drugs May Contain a Compound That is Proven To Cause Cancer | 4/6/2020
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.